NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/13/2025
Back to search
Official data from USPTO
BLENDED CRO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BLENDED CRO
ST13
US500000086126742Class
35, 42
Filing
86126742
Registration
4672867
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
07/08/2025
Trademark type
Word
Nice classes
35, 42
Filing date
11/22/2013
Registration date
01/13/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2025
Last transaction
07/08/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/02/2013
First use in commerce
10/02/2013
Drawing code
4
Owner type
03
Owner location
Raleigh, NC
Examiner
SCHRODY, ALLISON
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Bogier Clinical and IT Solutions, Inc.
Representatives
Eric Stevens POYNER SPRUILL LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Management of data from clinical trials for pharmaceutical drugsdatabase managementproviding information management servicesmanagement and compilation of computerized databases in the field of clinical trials for business purposes; business analysis of data from clinical trials for pharmaceutical drugs
Class 42
Medical and scientific research servicesusing "best of industry" suppliers to conduct clinical trials for pharmaceutical drugs for others; scientific analysis of data from clinical trials for pharmaceutical drugs; and providing quality assurance services in the field of clinical trials for pharmaceutical drugs
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/13/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/13/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/10/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
01/02/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/13/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/20/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/20/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/20/2020
E815
TEAS SECTION 8 & 15 RECEIVED
09/23/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/13/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
01/13/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/11/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/10/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/24/2014
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/20/2014
IUAF
USE AMENDMENT FILED
10/28/2014
EISU
TEAS STATEMENT OF USE RECEIVED
10/28/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/13/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/18/2014
PUBO
PUBLISHED FOR OPPOSITION
03/18/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/26/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/07/2014
ALIE
ASSIGNED TO LIE
02/05/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/15/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/09/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/09/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/09/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/06/2014
GNRT
NON-FINAL ACTION E-MAILED
01/06/2014
CNRT
NON-FINAL ACTION WRITTEN
01/06/2014
DOCK
ASSIGNED TO EXAMINER
12/30/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/06/2013
Continuous trademark protection
Get notified about every new filing that threatens BLENDED CRO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.